A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: Results from the FAMOUS study.

Goebell, P., Münch, A., Müller, L., Hurtz, H.-J., Koska, M., Busies, S., Marschner, N., 2014.

Urol Oncol 32, 362–370. doi:10.1016/j.urolonc.2013.09.009

Studie: TNK; Indikation: Nierenzellkarzinom; Jahr: 2014; Veranstaltung: -; Journal: Urologic Oncology

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com